NCT06772779View on ClinicalTrials.gov

A Study of Enlicitide Decanoate (MK-0616), Warfarin, and Lisinopril in Healthy Adult Participants (MK-0616-026)

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

June 4, 2024

Study Completion Date

June 4, 2024

Conditions
Healthy
Interventions
DRUG

Warfarin

single oral dose

DRUG

Enlicitide Decanoate

single oral dose

DRUG

Lisinopril

single oral dose

Trial Locations (1)

85283

Celerion (Site 0001), Tempe

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT06772779 - A Study of Enlicitide Decanoate (MK-0616), Warfarin, and Lisinopril in Healthy Adult Participants (MK-0616-026) | Biotech Hunter | Biotech Hunter